PK&PD
Toxicity study
   
 
 
 

Starvax is a global biotech company with an R&D center in Beijing, China. Focusing on the development of novel therapeutic drugs for the treatment of infectious disease and cancer, we also offer outsourcing service to meet the fast growing demand from the biomedical research communities and pharmaceutical industries. We strongly promote and encourage collaborations between our scientists and those of both the local community and worldwide.

People & Facility

PK&PD,preclinical CRO,toxicity study 30 full-time employees, most with advanced degrees in biomedical sciences
preclinical CRO,toxicity study,preclinical CRO Over 4,500 square-feet of research facility located in China's premier life science
park - Zhongguancun Life Science Park
Non-human primate experiments,preclinical CRO,toxicity study Standard lab equipment for molecular biology, biochemistry, immunology,
and cell biology
Non-human primate experiments,preclinical CRO Class 100,000 clean room
Non-human primate experiments,toxicity study Additional SPF animal housing facility

Competitive Advantages

Non-human primate experiments,toxicity study Stringent IP protection and confidentiality measurement
PK&PD,preclinical CRO High quality service at a fraction of the cost in the US or Europe
Non-human primate experiments Full English report with recording tracking
Non-human primate experiments,PK&PD,preclinical CRO,toxicity study Proven track record in collaborating with western biotech companies
preclinical CRO,toxicity study Strong strategic relationship with leading local research institutions
PK&PD,preclinical CRO,toxicity study Access to bio-safety level 3 animal facility

 

 

 
 

 

Pre-clinical Services £ü Non-human primate experiments £ü Immunohistochemistry (IHC) £ü Gene targeting service

Copyright © 2005, Starvax Inc. All Rights Reserved.